Surveys at a Glance

Please Login for Carts
or Register to get an account.

Please cite all information retrieved from the Gateway data as follows:
Gateway to Global Aging Data, Produced by the USC Program on Global Aging, Health & Policy, with funding from the National Institute on Aging (R01 AG030153)
HRS MHAS ELSA SHARE CRELES KLoSA JSTAR TILDA CHARLS LASI

United States

Mexico

England

20+ European Countries and Israel

Costa Rica

Korea

Japan

Ireland

China

India

Sample (Sample descriptions)
Respondent Eligibility                    
Age Eligibility 51 50 50 50 Cohort 1: 60 / Cohort 2: 55 45 50 50 45 45
One or all age-eligible one one all one† one all one all one all
Spouse inclusion regardless of age regardless of age regardless of age regardless of age Cohort 1: none / Cohort 2: regardless of age only if age eligible none regardless of age regardless of age regardless of age
Survey                    
Method in-person/ phone/ self-completion in-person in-person/self-completion in-person/self-completion in-person in-person in-person/self-completion in-person/self-completion in-person in-person
Number of waves collected 12 4* 7 6* 5 5 5* 2 2 1 (pilot)
Sample refreshment                    
Waves or frequency every 3 waves Wave 3 Waves 3, 4, 6, 7 Wave 2, 4, 5 none Wave 5 none none none none
Sample Size                    
At baseline 12,652 15,402 12,099 30,779 Cohort 1: 2,827 / Cohort 2: 2,798 10,254 3,742 8,504 17,705 1,683
At latest released wave 18,748 15,723 9,666 66,246 Cohort 1: 1,855 / Cohort 2: 2,430 7,029 5,138 7,207 15,180 1,683
Blood-based biomarker                    
Type dbs venous and dbs venous dbs venous none none venous venous dbs
dbs: dried blood spots.
The original Wave 1 sample of SHARE interviewed all age-eligible individuals in a household.
* Not all collected waves have been released
CAMS - Consumption and Activities Mail Survey; HUMS - Human Capital and Education Expenses Mail Survey; PDS - Prescription Drug Study
HRS ELSA SHARE JSTAR TILDA

United States

England

20+ European Countries and Israel

Japan

Ireland

1992-93
1994-95
1996-97
1998-99 HRS Mailout
2000-01 HUMS

CAMS
2002-03 CAMS

Diabetes Study
ELSA W1
2004-05 HRS W7 Disability

HRS W7 Psycho-Social

CAMS

PDS
ELSA W2

ELSA W2 Ryff
SHARE W1 Vignettes

SHARE W1 Drop-Off
2006-07 HRS W8 Psycho-Social

CAMS

Disability

PDS
ELSA W3

ELSA W3 Health

ELSA W3 Work
SHARE W2 Vignettes

SHARE W2 Drop-Off
JSTAR W1
2008-09 HRS W9 Psycho-Social

CAMS
ELSA W4
JSTAR W2
2010-11 HRS W10 Psycho-Social

CAMS
ELSA W5
SHARE W4 Drop-Off
JSTAR W3
TILDA W1
2012-13 HRS W11 Psycho-Social

CAMS
ELSA W6

Sexual questionnaires
SHARE W5 Drop-Off
TILDA W2
2014-15 HRS W12 Psycho-Social
HRS ELSA SHARE KLoSA CHARLS

United States

England

20+ European Countries and Israel

Korea

China

1992-93
1994-95
1996-97
1998-99
2000-01
2002-03
2004-05
2006-07 ELSA Life History

ELSA Life History Self Completion
KLoSA Job History
2008-09 SHARELIFE
2010-11
2012-13
2014-15 HRS Life History
CHARLS Life History


Concordance Tables for Life History Data

HRS MHAS ELSA SHARE KLoSA IFLS JSTAR SAGE TILDA CHARLS LASI

United States

Mexico

England

20+ European Countries and Israel

Korea

Indonesia

Japan

China, Ghana, India, Mexico, Russia and South Africa

Ireland

China

India

1992-93 IFLS W1 Anthropometry
1994-95
1996-97 IFLS W2 Health Measurements
1998-99
2000-01 MHAS W1 Anthropometric Measures
IFLS W3 Health Measurements
2002-03 MHAS W2 Anthropometric Measures
ELSA W1 Timed Walk
2004-05 HRS W7 Physical Measures
ELSA W2 Timed Walk

ELSA W2 Nurse Visit
SHARE W1 Walking Speed

SHARE W1 Grip Strength
2006-07 HRS W8 Physical Measures
ELSA W3 Timed Walk
SHARE W2 Walking Speed

SHARE W2 Grip Strength

SHARE W2 Peak Flow
KLoSA W1 Grip Strength
IFLS W4 Health Measurements
JSTAR W1 Grip Strength
2008-09 HRS W9 Physical Measures
ELSA W4 Timed Walk

ELSA W4 Nurse Visit
SHARELIFE Grip Strength
KLoSA W2 Grip Strength
JSTAR W2 Grip Strength
CHARLS Pilot Biomarker
2010-11 HRS W10 Physical Measures
ELSA W5 Timed Walk
SHARE W4 Timed Walk
KLoSA W3 Grip Strength
SAGE W1 Performance Tests & Biomarkers

SAGE W1 Retest Performance Tests & Biomarkers
TILDA W1 Health Assessment
LASI Pilot Biomarker
2012-13
2014-15
HRS MHAS ELSA SHARE KLoSA JSTAR SAGE CHARLS

United States

Mexico

England

20+ European Countries and Israel

Korea

Japan

China, Ghana, India, Mexico, Russia and South Africa

China

1992-93
1994-95 AHEAD 1995 W2
1996-97 HRS W3
1998-99 HRS W4

HRS W4 Post-Exit
2000-01 HRS W5

HRS W5 Post-Exit
2002-03 HRS W6

HRS W6 Post-Exit
MHAS W2
2004-05 HRS W7

HRS W7 Post-Exit
ELSA W2
2006-07 HRS W8

HRS W8 Post-Exit
ELSA W3
SHARE W2
2008-09 HRS W9

HRS W9 Post-Exit
ELSA W4
SHARELIFE
KLoSA W2
JSTAR W2
2010-11 HRS W10

HRS W10 Post-Exit
SHARE W4
KLoSA W3
JSTAR W3
SAGE W1
2012-13 HRS W11

HRS W11 Post-Exit
MHAS W3
ELSA W6
SHARE W5
KLoSA W4
CHARLS W2
2014-15 HRS W12


Exit Data Variable Table

IFLS SAGE CHARLS

Indonesia

China, Ghana, India, Mexico, Russia and South Africa

China

1992-93 IFLS W1
1994-95
1996-97 IFLS W2
1998-99
2000-01 IFLS W3
2002-03
2004-05
2006-07 IFLS W4
2008-09 CHARLS Pilot District

CHARLS Pilot Community
2010-11 SAGE Pilot
2012-13
2014-15